Comparative Efficacy and Clinical Outcomes of Haploidentical Stem Cell Transplantation to Other Stem Sources for Treatment in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis

The use of allogeneic hematopoietic stem cell transplantation (HSCT) is recommended during the first complete remission of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). However, only 30% of these cases have fully matched sibling donors (MSDs). Alternatively, matched unre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunacheewa, Chutima, Ungprasert, Patompong, Phikulsod, Ployploen, Issaragrisil, Surapol, Owattanapanich, Weerapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444220/
https://www.ncbi.nlm.nih.gov/pubmed/32323567
http://dx.doi.org/10.1177/0963689720904965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444220/
https://www.ncbi.nlm.nih.gov/pubmed/32323567
http://dx.doi.org/10.1177/0963689720904965

Ejemplares similares